Riskpilot← Back to searchSign inGet full accessELITE HELSE AS
ASActiveOrg 994552813Salmsv M. Jantzens Pl 4, 0252 OsloAndre helsetjenester · NACE 86909Est. 20096 employeeswww.elitehelse.com
Revenue 2022
NOK 15,7M
+19% vs 2021
EBITDA margin
5.6%
+43% vs 2021
Equity ratio
30.4%
Financial strength
Net profit 2022
NOK 443K
+149% vs 2021
| Revenue | NOK 15,7M | +19% |
| EBITDA | NOK 885K | +43% |
| Net profit | NOK 443K | +149% |
| Total assets | NOK 3,7M | +10% |
| Equity | NOK 1,1M | +64% |
| Employees | 6 | — |
Legal name
ELITE HELSE AS
Org number
994552813
Legal form
Aksjeselskap
NACE code
86909 · Andre helsetjenester
Founded
30. september 2009
Share capital
NOK 14 290 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drive colon hydroterapitjenester, detoxtjenester og annen medisinsk behandilig og alt som står i forbindelse hermed, herunder eiendomsdrift og deltagelse i andre selskaper.
Address
Salmsv M. Jantzens Pl 4, 0252 Oslo
Website
www.elitehelse.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 11 655 | 12 843 | 13 386 | 13 209 | 15 700 |
| Staff expenses | −1 205 | −5 366 | −4 638 | −4 963 | −6 234 |
| EBITDA | 716 | 681 | 1 518 | 618 | 885 |
| Depreciation & amort. | −314 | −345 | −360 | −1 719 | −226 |
| EBIT | 401 | 336 | 1 158 | −1 101 | 659 |
| Net financials | −53 | −94 | −60 | −53 | −51 |
| Profit before tax | 348 | 242 | 1 098 | −1 154 | 608 |
| Tax | 101 | 56 | 254 | −242 | 166 |
| Net profit | 247 | 186 | 845 | −912 | 443 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 3 831 | 4 182 | 4 396 | 3 397 | 3 746 |
| Equity | 1 737 | 1 562 | 1 607 | 695 | 1 137 |
| Long-term debt | 1 348 | 1 208 | 1 133 | 963 | 813 |
| Short-term debt | 746 | 1 412 | 1 656 | 1 740 | 1 796 |
| Total debt | 2 094 | 2 620 | 2 789 | 2 702 | 2 609 |
EBITDA margin
5.6%
This company
15.8%
Market median
-65% vs market
20182022
Equity ratio
30.4%
This company
38.2%
Market median
+20% vs market
20182022
Return on equity
38.9%
This company
18.4%
Market median
+111% vs market
20182022
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20182022
Asset turnover
4.19×
This company
1.12×
Market median
+274% vs market
20182022
Debt / equity
2.29×
This company
0.62×
Market median
-269% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LS Chief Executive Officer | Chief Executive Officer | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 34.99% | 34.99% | 2022 | |
| Company | 15.05% | 15.05% | 2022 | |
| Company | 14.98% | 14.98% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Suta As
ELITE HELSE AS Board members of ELITE HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laura Suta | Chief Executive Officer | 0 companies |
| Isabella Bukurie Bessières | Chairman | 0 companies |